Cargando…
Humanized Mouse Model Mimicking Pathology of Human Tuberculosis for in vivo Evaluation of Drug Regimens
Human immune system mice are highly valuable for in vivo dissection of human immune responses. Although they were employed for analyzing tuberculosis (TB) disease, there is little data on the spatial organization and cellular composition of human immune cells in TB granuloma pathology in this model....
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6365439/ https://www.ncbi.nlm.nih.gov/pubmed/30766535 http://dx.doi.org/10.3389/fimmu.2019.00089 |
_version_ | 1783393417220325376 |
---|---|
author | Arrey, Frida Löwe, Delia Kuhlmann, Stefanie Kaiser, Peggy Moura-Alves, Pedro Krishnamoorthy, Gopinath Lozza, Laura Maertzdorf, Jeroen Skrahina, Tatsiana Skrahina, Alena Gengenbacher, Martin Nouailles, Geraldine Kaufmann, Stefan H. E. |
author_facet | Arrey, Frida Löwe, Delia Kuhlmann, Stefanie Kaiser, Peggy Moura-Alves, Pedro Krishnamoorthy, Gopinath Lozza, Laura Maertzdorf, Jeroen Skrahina, Tatsiana Skrahina, Alena Gengenbacher, Martin Nouailles, Geraldine Kaufmann, Stefan H. E. |
author_sort | Arrey, Frida |
collection | PubMed |
description | Human immune system mice are highly valuable for in vivo dissection of human immune responses. Although they were employed for analyzing tuberculosis (TB) disease, there is little data on the spatial organization and cellular composition of human immune cells in TB granuloma pathology in this model. We demonstrate that human immune system mice, generated by transplanted human fetal liver derived hematopoietic stem cells develop a continuum of pulmonary lesions upon Mycobacterium tuberculosis aerosol infection. In particular, caseous necrotic granulomas, which contribute to prolonged TB treatment time, developed, and had cellular phenotypic spatial-organization similar to TB patients. By comparing two recommended drug regimens, we confirmed observations made in clinical settings: Adding Moxifloxacin to a classical chemotherapy regimen had no beneficial effects on bacterial eradication. We consider this model instrumental for deeper understanding of human specific features of TB pathogenesis and of particular value for the pre-clinical drug development pipeline. |
format | Online Article Text |
id | pubmed-6365439 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-63654392019-02-14 Humanized Mouse Model Mimicking Pathology of Human Tuberculosis for in vivo Evaluation of Drug Regimens Arrey, Frida Löwe, Delia Kuhlmann, Stefanie Kaiser, Peggy Moura-Alves, Pedro Krishnamoorthy, Gopinath Lozza, Laura Maertzdorf, Jeroen Skrahina, Tatsiana Skrahina, Alena Gengenbacher, Martin Nouailles, Geraldine Kaufmann, Stefan H. E. Front Immunol Immunology Human immune system mice are highly valuable for in vivo dissection of human immune responses. Although they were employed for analyzing tuberculosis (TB) disease, there is little data on the spatial organization and cellular composition of human immune cells in TB granuloma pathology in this model. We demonstrate that human immune system mice, generated by transplanted human fetal liver derived hematopoietic stem cells develop a continuum of pulmonary lesions upon Mycobacterium tuberculosis aerosol infection. In particular, caseous necrotic granulomas, which contribute to prolonged TB treatment time, developed, and had cellular phenotypic spatial-organization similar to TB patients. By comparing two recommended drug regimens, we confirmed observations made in clinical settings: Adding Moxifloxacin to a classical chemotherapy regimen had no beneficial effects on bacterial eradication. We consider this model instrumental for deeper understanding of human specific features of TB pathogenesis and of particular value for the pre-clinical drug development pipeline. Frontiers Media S.A. 2019-01-31 /pmc/articles/PMC6365439/ /pubmed/30766535 http://dx.doi.org/10.3389/fimmu.2019.00089 Text en Copyright © 2019 Arrey, Löwe, Kuhlmann, Kaiser, Moura-Alves, Krishnamoorthy, Lozza, Maertzdorf, Skrahina, Skrahina, Gengenbacher, Nouailles and Kaufmann. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Immunology Arrey, Frida Löwe, Delia Kuhlmann, Stefanie Kaiser, Peggy Moura-Alves, Pedro Krishnamoorthy, Gopinath Lozza, Laura Maertzdorf, Jeroen Skrahina, Tatsiana Skrahina, Alena Gengenbacher, Martin Nouailles, Geraldine Kaufmann, Stefan H. E. Humanized Mouse Model Mimicking Pathology of Human Tuberculosis for in vivo Evaluation of Drug Regimens |
title | Humanized Mouse Model Mimicking Pathology of Human Tuberculosis for in vivo Evaluation of Drug Regimens |
title_full | Humanized Mouse Model Mimicking Pathology of Human Tuberculosis for in vivo Evaluation of Drug Regimens |
title_fullStr | Humanized Mouse Model Mimicking Pathology of Human Tuberculosis for in vivo Evaluation of Drug Regimens |
title_full_unstemmed | Humanized Mouse Model Mimicking Pathology of Human Tuberculosis for in vivo Evaluation of Drug Regimens |
title_short | Humanized Mouse Model Mimicking Pathology of Human Tuberculosis for in vivo Evaluation of Drug Regimens |
title_sort | humanized mouse model mimicking pathology of human tuberculosis for in vivo evaluation of drug regimens |
topic | Immunology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6365439/ https://www.ncbi.nlm.nih.gov/pubmed/30766535 http://dx.doi.org/10.3389/fimmu.2019.00089 |
work_keys_str_mv | AT arreyfrida humanizedmousemodelmimickingpathologyofhumantuberculosisforinvivoevaluationofdrugregimens AT lowedelia humanizedmousemodelmimickingpathologyofhumantuberculosisforinvivoevaluationofdrugregimens AT kuhlmannstefanie humanizedmousemodelmimickingpathologyofhumantuberculosisforinvivoevaluationofdrugregimens AT kaiserpeggy humanizedmousemodelmimickingpathologyofhumantuberculosisforinvivoevaluationofdrugregimens AT mouraalvespedro humanizedmousemodelmimickingpathologyofhumantuberculosisforinvivoevaluationofdrugregimens AT krishnamoorthygopinath humanizedmousemodelmimickingpathologyofhumantuberculosisforinvivoevaluationofdrugregimens AT lozzalaura humanizedmousemodelmimickingpathologyofhumantuberculosisforinvivoevaluationofdrugregimens AT maertzdorfjeroen humanizedmousemodelmimickingpathologyofhumantuberculosisforinvivoevaluationofdrugregimens AT skrahinatatsiana humanizedmousemodelmimickingpathologyofhumantuberculosisforinvivoevaluationofdrugregimens AT skrahinaalena humanizedmousemodelmimickingpathologyofhumantuberculosisforinvivoevaluationofdrugregimens AT gengenbachermartin humanizedmousemodelmimickingpathologyofhumantuberculosisforinvivoevaluationofdrugregimens AT nouaillesgeraldine humanizedmousemodelmimickingpathologyofhumantuberculosisforinvivoevaluationofdrugregimens AT kaufmannstefanhe humanizedmousemodelmimickingpathologyofhumantuberculosisforinvivoevaluationofdrugregimens |